Sign In
Buy ORGO
$2.33
+0.0900 (+4.02%)
At Close: Jun 03, 2026
BTIG Keeps a Buy Rating on Organogenesis Holdings (ORGO)
03:14pm, Tuesday, 10'th Mar 2020
BTIG analyst Ryan Zimmerman maintained a Buy rating on Organogenesis Holdings (ORGO) yesterday and set a price target of $9.00. The company's shares
Organogenesis Holdings (ORGO) Receives a Buy from Oppenheimer
01:09pm, Tuesday, 10'th Mar 2020
In a report released today, Steven Lichtman from Oppenheimer maintained a Buy rating on Organogenesis Holdings (ORGO), with a price target of $9.00. The
Organogenesis Holdings (ORGO) Receives a Buy from Oppenheimer
01:09pm, Tuesday, 10'th Mar 2020
In a report released today, Steven Lichtman from Oppenheimer maintained a Buy rating on Organogenesis Holdings (ORGO – Research Report),
Organogenesis Holdings Inc. (ORGO) CEO Gary S. Gillheeney, Sr. on Q4 2019 Results - Earnings Call Transcript
01:01am, Tuesday, 10'th Mar 2020
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2019 Earnings Conference Call March 09, 2020 5:00 PM ET Company Participants Gary S. Gillheeney, Sr. - President &a
Organogenesis Holdings Inc (ORGO) Q4 2019 Earnings Call Transcript
01:00am, Tuesday, 10'th Mar 2020
ORGO earnings call for the period ending December 31, 2019.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
Organogenesis up 26% after hours on Q4 beat
08:45pm, Monday, 09'th Mar 2020
Organogenesis (NASDAQ:ORGO) Q4 results:Revenue: $74.6M (+16.8%); Advanced Would Care: $63.4M (+16.1%); Surgical & Sports Medicine: $11.3M (+25.6%).Increase in AWC due to execution of additional sa
Organogenesis: 4Q Earnings Snapshot
08:43pm, Monday, 09'th Mar 2020
CANTON, Mass. (AP) _ Organogenesis Holdings Inc. (ORGO) on Monday reported a loss of $4.4 million in its fourth quarter.
On a per-share basis, the Canton, Massachusetts-based company said it had a los
CANTON, Mass., March 09, 2020 -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and.
CANTON, Mass., March 09, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the...
Organogenesis Holdings, Inc. to Host Earnings Call
07:00pm, Monday, 09'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 9, 2020 / Organogenesis Holdings, Inc. (ORGO) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 9, 2020 at 5:00
Organogenesis (NASDAQ:ORGO) PT Lowered to $8.00 at Credit Suisse Group
09:50am, Monday, 09'th Mar 2020
Organogenesis (NASDAQ:ORGO) had its target price cut by Credit Suisse Group from $10.00 to $8.00 in a report published on Friday morning, The Fly reports. They currently have an outperform rating on t
Organogenesis Holdings (ORGO) Gets a Buy Rating from Credit Suisse
10:19am, Sunday, 08'th Mar 2020
Credit Suisse analyst Matt Miksic reiterated a Buy rating on Organogenesis Holdings (ORGO – Research Report) on March 6 and
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
12:00am, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) * Arcus Biosciences Inc (NYSE: RCUS) * Arcturu
